ACRP blog
MAY 5, 2025
This is a sponsored message. If you’ve led a clinical development program, you likely know something all too well: theres a constrained pipeline of qualified principal investigators (PIs), and a high prevalence of “one-and-done” PIs. About half of all PIs conduct only a single clinical trial in their careers before walking away. This isn’t simply another negative byproduct of turnover.
Bio Pharma Dive
MAY 6, 2025
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 7, 2025
Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.
Rethinking Clinical Trials
MAY 9, 2025
Speaker Roland RJ van Kimmenade, MD, PhD Cardiologist, Radboud University Medical Center Nijmegen, the Netherlands Slides Keywords Heart Failure; Fluids; Cardiology Key Points We are facing a pandemic of heart failure (HF), with an incidence of 1 20 cases of heart failure per 1,000 people. The incidence of HF is stable if not declining but mortality remains high, at about 15 30% after one year.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
Medical Xpress
MAY 3, 2025
Researchers led by the Trondheim University Hospital in Norway report that two hours of immediate skin-to-skin contact between mothers and very preterm infants after birth does not improve cognitive, motor, or language development by age 2 to 3 years. Infants receiving the intervention did show significantly improved breastfeeding outcomes.
Bio Pharma Dive
MAY 5, 2025
The cuts to three advanced drug programs were “inevitable” given the company’s “unsustainable cash burn,” one analyst wrote in a note to investors.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
MAY 9, 2025
The FDA has granted approval to Abeona Therapeutics Zevaskyn (prademagene zamikeracel, also known as pz-cel), marking it as the first and only cell-based gene therapy approved for the rare skin disease recessive dystrophic epidermolysis bullosa (RDEB). The therapy is described as an autologous cell sheet-based gene therapy that acts as a skin graft.
Rethinking Clinical Trials
MAY 6, 2025
The Nudge Unit at Penn Medicine opened registration and abstract submissions for the 2025 Nudges in Health Care Symposium. The event is “focused on exploring the application of behavioral economics principles and nudges in healthcare settings.” The Nudge Unit is supported by Center for Health Care Transformation and Innovation and thePenn Center for Health Incentives and Behavioral Economics.
Bio Pharma Dive
MAY 5, 2025
The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices and healthcare services.
Pharmaceutical Technology
MAY 5, 2025
The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Pharma Times
MAY 7, 2025
Demonstrate your skill and prowess by entering this year's awards!
Medical Xpress
MAY 4, 2025
Reading is a highly valuable skill that allows humans to acquire new knowledge, pursue an education and complete a wide range of real-world tasks.
pharmaphorum
MAY 7, 2025
Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them
Pharmaceutical Technology
MAY 9, 2025
HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
MAY 5, 2025
While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less clear-cut.
JAMA Internal Medicine
MAY 4, 2025
This Viewpoint examines the urinary nitrite test and questions its effectiveness and relevance in distinguishing between urinary tract infection and asymptomatic bacteriuria.
Medical Xpress
MAY 3, 2025
"Theories are like toothbrushes," it's sometimes said. "Everybody has their own and nobody wants to use anybody else's.
Pharmaceutical Technology
MAY 6, 2025
Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To rise to these challenges, the biopharma industry continues to develop innovative strategies to bring vital therapies swiftly to rare disease patients.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 8, 2025
A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical acute pain. Viatris now plans to file for approval this year.
pharmaphorum
MAY 7, 2025
AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time
Medical Xpress
MAY 4, 2025
Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.
Pharmaceutical Technology
MAY 6, 2025
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), once focused on treating diabetes and obesity, are now emerging as potential treatments for a broader range of chronic conditions, including metabolic dysfunction-associated steatohepatitis and Alzheimers disease.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Bio Pharma Dive
MAY 8, 2025
The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and operational investments in U.S. drug manufacturing.
pharmaphorum
MAY 7, 2025
An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?
XTalks
MAY 7, 2025
Fortune, in collaboration with Premier, Inc., has unveiled its 2025 list of the 100 Top Hospitals in the United States. This ranking evaluates hospitals based on clinical outcomes, patient experience, operational efficiency and financial health. You can explore this table to view the top 100 hospitals in the US according to Fortune Premier Rankings, with 20 in each category: major teaching hospitals, teaching hospitals, large community hospitals, medium community hospitals and small community h
Pharmaceutical Technology
MAY 7, 2025
Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and diabetes drugs.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Rethinking Clinical Trials
MAY 7, 2025
The Big Picture: Healthcare Data and Interoperability Description In this video, Dr. Lesley Curtis explores how data flow into EHRs and move between systems, the role of data standards, and the barriers to building a more streamlined and connected healthcare system. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair Related Electronic Health RecordsBased Phenotyping The post The
pharmaphorum
MAY 9, 2025
GSK reveals the data behind its linerixibat for itching associated with autoimmune liver disease PBC as it anticipates first approvals for the drug.
XTalks
MAY 6, 2025
Gastrointestinal (GI) disorders pose major challenges in modern healthcare. In the US, nearly 45 million adults suffer from nonerosive gastroesophageal reflux disease (GERD) , while more than 15 million receive prescription treatments for its erosive form. Nonerosive GERD shows typical reflux symptoms without visible esophageal damage, whereas erosive GERD causes clear injury to the esophageal lining.
Pharmaceutical Technology
MAY 6, 2025
Teva and Alvotech have announced receipt of the US FDA approval to Selarsdi injection for use as an interchangeable with Stelara.
Expert insights. Personalized for you.
59 
Let's personalize your content